M
Matthew Ierullo
Researcher at University Health Network
Publications - 11
Citations - 609
Matthew Ierullo is an academic researcher from University Health Network. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 4, co-authored 11 publications receiving 108 citations.
Papers
More filters
Journal ArticleDOI
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Victoria G Hall,Victor H Ferreira,Terrance Ku,Matthew Ierullo,Beata Majchrzak-Kita,C. Chaparro,Nazia Selzner,Jeffrey Schiff,Michael McDonald,George Tomlinson,Vathany Kulasingam,Deepali Kumar,Atul Humar +12 more
TL;DR: A Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal response to SARS-C...
Journal ArticleDOI
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients.
Victoria G Hall,Victor H Ferreira,Matthew Ierullo,Terrance Ku,Tina Marinelli,Beata Majchrzak-Kita,Anila Yousuf,Vathany Kulasingam,Atul Humar,Deepali Kumar +9 more
TL;DR: In this paper, the authors assessed the immunogenicity of mRNA-1273 COVID-19 vaccine using a combination of antibody testing, surrogate neutralization assays, and T cell assays.
Journal ArticleDOI
Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients.
Tina Marinelli,Victor H Ferreira,Matthew Ierullo,Terrance Ku,Les Lilly,S. Joseph Kim,Jeffrey Schiff,Aman Sidhu,Michael McDonald,Seyed M Hosseini-Moghaddam,Shahid Husain,Coleman Rotstein,Beata Majchrzak-Kita,Vathany Kulasingam,Atul Humar,Deepali Kumar +15 more
TL;DR: In this article, a comprehensive overview of COVID-19 in transplant recipients over a 12-mo period and the lessons learned regarding the clinical course, outcomes, complications, and in a subset of patients antibody response and viral shedding in the prevaccination era.
Journal ArticleDOI
Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients.
Arnaud G LʼHuillier,Cedric Hirzel,Victor H Ferreira,Matthew Ierullo,Terrance Ku,Nazia Selzner,Jeffrey Schiff,Stephen C. Juvet,Congrong Miao,D. Scott Schmid,Atul Humar,Deepali Kumar +11 more
TL;DR: In this article, the recombinant subunit herpes zoster vaccine (RZV) was used for varicella-zoster virus (VZV)-seronegative solid organ transplant (SOT) patients.
Journal ArticleDOI
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
Victor H Ferreira,Andrzej Chruscinski,Vathany Kulasingam,Trevor J. Pugh,Trevor J. Pugh,Trevor J. Pugh,Tamara Dus,Brad Wouters,Amit M. Oza,Matthew Ierullo,Terrance Ku,Beata Majchrzak-Kita,Sonika T. Humar,Ilona Bahinskaya,Natalia Pinzon,Jianhua Zhang,Lawrence E. Heisler,Paul M. Krzyzanowski,Bernard Lam,Ilinca Lungu,Dorin Manase,Krista M. Pace,Pouria Mashouri,Michael Brudno,Michael Garrels,Tony Mazzulli,Myron I. Cybulsky,Atul Humar,Deepali Kumar +28 more
TL;DR: In this article, the authors performed a cross-sectional study looking at asymptomatic SARS-CoV-2 infection in HCWs and showed the utility of routine screening of health care workers, which may help identify a significant proportion of infections.